Prescreening Protocol to Enroll in Food Allergy Clinical Studies at a Single Site (Prescreen)

March 12, 2024 updated by: Sayantani B. Sindher, Stanford University
This is a protocol for prescreening of participants who would like to be in clinical studies in our Center at Stanford.

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

800

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • California
      • Palo Alto, California, United States, 94304
        • Recruiting
        • The Sean N. Parker Center for Allergy and Asthma Research, Stanford University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 week to 90 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Ages 1 wk-90 yrs will be screened and enrolled in this study to determine if they have a clinically-relevant food allergy. If so, they could be eligible for interventional clinical trials in the future.

Description

Inclusion Criteria:

  • Any individual with possible food allergy (as per their clinical history) who is interested in performing the gold standard food challenge for diagnosis.

Exclusion Criteria:

  • Any individual who does not consent
  • Any individual who is currently taking oral steroids
  • Any individual with moderate to severe asthma (FEV1<80%)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Other

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Outcome of standardized food challenges
Time Frame: 1 year
Standardized Oral food challenges will occur in a staged manner to diagnose food allergies
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
skin testing will occur to evaluate food allergen responses
Time Frame: 1 year
Standardized skin testing will be performed to detect sensitivity to food allergens
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sayantani Sindher, MD, Stanford University, SNP Center for Food Allergy and Asthma Research

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 10, 2018

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

May 16, 2018

First Submitted That Met QC Criteria

May 16, 2018

First Posted (Actual)

May 29, 2018

Study Record Updates

Last Update Posted (Actual)

March 15, 2024

Last Update Submitted That Met QC Criteria

March 12, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 34738
  • 1UM1AI130839-01 (U.S. NIH Grant/Contract)
  • 5U19AI104209-07 (U.S. NIH Grant/Contract)
  • FY20ITN384 (Other Grant/Funding Number: NIH Prime Immune Tolerance Network)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Food Allergy

3
Subscribe